Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Detail)

v3.20.2
Accrued Expenses - Schedule of Accrued Expenses (Detail) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Accrued Liabilities Current [Abstract]    
External research and preclinical development $ 5,651 $ 5,395
Employee compensation and benefits 3,924 4,174
Professional fees 667 694
Facilities and other 43 383
Total accrued expenses $ 10,285 $ 10,646